Topic Hub
14 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 14 of 14 clinical reviews.
Complete caregiver guide to applying AndroGel testosterone gel in adolescents aged 12 to 17, including dosing, application sites, transfer prevention, missed doses, and when to call the prescriber.
Read clinical reviewA clinical guide for adolescents aged 12 to 17 on AndroGel testosterone gel and their transition to adult endocrinology or primary care, covering dose conversion, monitoring schedules, and shared decision-making.
Read clinical reviewA clinician-reviewed guide covering how AndroGel (testosterone gel) affects school performance, sports eligibility, PE class, transfer risk, and daily scheduling for adolescents aged 12 to 17.
Read clinical reviewA clinical guide to AndroGel (testosterone gel 1% and 1.62%) use in men aged 65 and older, covering dosing, safety monitoring, cardiovascular risk, and transition-of-care protocols backed by primary-source evidence.
Read clinical reviewA complete clinical guide to AndroGel (testosterone gel 1% and 1.62%) caregiver administration for men 65 and older, covering application technique, transfer prevention, safety monitoring, and dose adjustment.
Read clinical reviewA physician-reviewed guide to AndroGel (testosterone gel) use in adolescents aged 12 to 17, covering bone age advancement, growth plate closure, pubertal staging, cardiovascular effects, and FDA-approved indications.
Read clinical reviewA physician-reviewed guide to off-label AndroGel (testosterone gel 1% and 1.62%) use in adolescents aged 12 to 17, covering indications, dosing, safety, monitoring, and current clinical guidelines.
Read clinical reviewAndroGel (testosterone gel 1%/1.62%) is FDA-approved for adult men only. This evidence-based guide covers the rare off-label scenarios where topical testosterone is considered in children under 12, including microphallus, delayed puberty, and accidental exposure risks.
Read clinical reviewA clinician-reviewed guide to AndroGel (testosterone gel 1%/1.62%) use in men aged 65+, covering pharmacokinetics, cardiovascular risk, bone and cognitive effects, dosing, and monitoring protocols backed by primary trial data.
Read clinical reviewA clinician-reviewed guide to AndroGel (testosterone gel 1%/1.62%) use in men aged 65 and older, covering FDA labeling, off-label considerations, the TTrials findings, cardiovascular and hematologic risks, dosing, and monitoring protocols.
Read clinical reviewA physician-reviewed guide for caregivers of children under 12 on AndroGel (testosterone gel) exposure risks, safe handling protocols, and what to do if accidental contact occurs.
Read clinical reviewA comprehensive clinical review of AndroGel (testosterone gel) developmental risks in children under 12, covering accidental exposure, virilization, bone age advancement, and FDA safety guidance.
Read clinical reviewA clinician-reviewed guide covering AndroGel (testosterone gel) transfer risks, school protocols, sports participation rules, and caregiver instructions for children under 12 exposed or prescribed testosterone gel.
Read clinical reviewA clinical guide to transitioning pediatric patients under 12 who use AndroGel (testosterone gel) into adult endocrine care, covering dosing, monitoring, bone age, and long-term safety.
Read clinical review